visitante ::
identificación
|
|||||||||||||||
Buscar | Enviar | Ayuda | Servicio de Bibliotecas | Sobre el DDD | Català English Español |
Página principal > Artículos > Artículos publicados > Urine NMR-based TB metabolic fingerprinting for the diagnosis of TB in children |
Fecha: | 2021 |
Resumen: | Tuberculosis (TB) is a major cause of morbidity and mortality in children, and early diagnosis and treatment are crucial to reduce long-term morbidity and mortality. In this study, we explore whether urine nuclear magnetic resonance (NMR)-based metabolomics could be used to identify differences in the metabolic response of children with different diagnostic certainty of TB. We included 62 children with signs and symptoms of TB and 55 apparently healthy children. Six of the children with presumptive TB had bacteriologically confirmed TB, 52 children with unconfirmed TB, and 4 children with unlikely TB. Urine metabolic fingerprints were identified using high- and low-field proton NMR platforms and assessed with pattern recognition techniques such as principal components analysis and partial least squares discriminant analysis. We observed differences in the metabolic fingerprint of children with bacteriologically confirmed and unconfirmed TB compared to children with unlikely TB (p = 0. 041 and p = 0. 013, respectively). Moreover, children with unconfirmed TB with X-rays compatible with TB showed differences in the metabolic fingerprint compared to children with non-pathological X-rays (p = 0. 009). Differences in the metabolic fingerprint in children with different diagnostic certainty of TB could contribute to a more accurate characterisation of TB in the paediatric population. The use of metabolomics could be useful to improve the prediction of TB progression and diagnosis in children. |
Ayudas: | Ministerio de Economía y Competitividad SAF2017-84324-C2-1-R Ministerio de Economía y Competitividad PID2019-110137RB-I00 Ministerio de Economía y Competitividad SAF2017-84324-C2-1-R Ministerio de Economía y Competitividad PID2019-110137RB-I00 Ministerio de Economía y Competitividad SAF2017-84324-C2-1-R Ministerio de Economía y Competitividad PID2019-110137RB-I00 Instituto de Salud Carlos III PI17/01487 Instituto de Salud Carlos III PIC18/00014 Instituto de Salud Carlos III ICI19/00039 Instituto de Salud Carlos III PI18/00256 Instituto de Salud Carlos III PI18/01227 Instituto de Salud Carlos III ICI20/00135 Instituto de Salud Carlos III PI17/01487 Instituto de Salud Carlos III PIC18/00014 Instituto de Salud Carlos III ICI19/00039 Instituto de Salud Carlos III PI18/00256 Instituto de Salud Carlos III PI18/01227 Instituto de Salud Carlos III ICI20/00135 Agència de Gestió d'Ajuts Universitaris i de Recerca 2017-SGR-483 Agència de Gestió d'Ajuts Universitaris i de Recerca 2019PROD00122 Agència de Gestió d'Ajuts Universitaris i de Recerca 2017-SGR-483 Agència de Gestió d'Ajuts Universitaris i de Recerca 2019PROD00122 Agència de Gestió d'Ajuts Universitaris i de Recerca 2017-SGR-483 Agència de Gestió d'Ajuts Universitaris i de Recerca 2019PROD00122 "la Caixa" Foundation HR17-00627 "la Caixa" Foundation CI20-00230 "la Caixa" Foundation HR17-00627 "la Caixa" Foundation CI20-00230 "la Caixa" Foundation HR17-00627 "la Caixa" Foundation CI20-00230 |
Derechos: | Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. |
Lengua: | Anglès |
Documento: | Article ; recerca ; Versió publicada |
Materia: | Metabolomics ; Tuberculosis ; Diagnostic markers ; NMR spectroscopy |
Publicado en: | Scientific reports, Vol. 11 (june 2021) , ISSN 2045-2322 |
11 p, 1.7 MB |